Sona Hubackova-Stemberkova
Prague, PR, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Heart failure and its progression is associated with changed lymphocyte profile in epicardial adipose tissue.
Journal: Frontiers in immunology
Published: May 07, 2026
Impact of a durable left ventricular assist device on inflammation and cardiac remodelling in subjects with advanced heart failure.
Journal: Open heart
Published: April 26, 2026
SGLT2 inhibitor therapy is associated with IL-10/TGF-α/sVEGFR3 signalling and adipose tissue remodelling in advanced heart failure.
Journal: Journal of molecular and cellular cardiology plus
Published: April 23, 2026
Breaking barriers in pulmonary health of patients with metabolic diseases: senolytics and beyond.
Journal: Frontiers in aging
Published: February 17, 2026
Epicardial adipose tissue produces L-3-hydroxybutyrate in advanced heart failure: direct analysis of fat metabolic remodeling.
Journal: Metabolism: clinical and experimental
Published: August 27, 2025
Coming of age: could obesity-related metabolic complications be treated by targeting senescent cells?
Journal: Frontiers in cell and developmental biology
Published: May 02, 2025
Role of ANT2 in mitochondrial function and cancer cell survival: a target for therapeutic intervention.
Journal: Cell death discovery
Published: November 28, 2024
Sodium-glucose cotransporter 2 inhibitors induce anti-inflammatory and anti-ferroptotic shift in epicardial adipose tissue of subjects with severe heart failure.
Journal: Cardiovascular diabetology
Published: March 03, 2024
Mitochondrially targeted tamoxifen as anticancer therapy: case series of patients with renal cell carcinoma treated in a phase I/Ib clinical trial.
Journal: Therapeutic advances in medical oncology
Published: March 28, 2023
Mitochondrial respiration supports autophagy to provide stress resistance during quiescence.
Journal: Autophagy
Published: March 08, 2022
Complex Positive Effects of SGLT-2 Inhibitor Empagliflozin in the Liver, Kidney and Adipose Tissue of Hereditary Hypertriglyceridemic Rats: Possible Contribution of Attenuation of Cell Senescence and Oxidative Stress.
Journal: International journal of molecular sciences
Published: September 02, 2021
Last Updated: 09/26/2026